Skip to main content
. Author manuscript; available in PMC: 2012 Sep 24.
Published in final edited form as: Epidemiology. 2011 Jul;22(4):589–597. doi: 10.1097/EDE.0b013e3182117c85

Table 1.

Logistic regression results on 924 women at their 4th study visit

Outcome Variable: LAB status (gold standard)
Variable β^ (std. error) Estimated OR (95% CI)
Race/Ethnicity (Black vs. White/Hispanic) 0.95 (0.15) 2.59 (1.94 – 3.46)
Risk Group (IDU vs. sex) 0.40 (0.14) 1.50 (1.13 – 1.98)
HIV Status (positive vs negative) 0.17 (0.15) 1.19 (0.89 – 1.60)
Age (years) −0.06 (0.01) 0.95 (0.92 – 0.97)
Outcome Variable: CLIN status (error-prone)
Race/Ethnicity (Black vs. White/Hispanic) 0.82 (0.17) 2.28 (1.63 – 3.20)
Risk Group (IDU vs. sex) 0.98 (0.17) 2.68 (1.93 – 3.73)
HIV Status (positive vs negative) −0.35 (0.17) 0.71 (0.51 – 0.99)
Age (years) −0.07 (0.01) 0.94 (0.91 – 0.96)

IDU indicates intravenous drug use.